More hair loss drugs make combination decisions the hard part
Benjamin sees the Lilly and Hims GLP-1 deal as a sign that large manufacturers will partner with online prescribers. If new hair compounds arrive as add-ons, Benjamin argues, specialist dermatologists are better suited than volume platforms to design each patient's combination.